Haematococcus astaxanthin: Applications for human health and nutrition

Trends in Biotechnology

Volumn 21, Issue 5, 2003, Pages 210-216

  Guerin, Martin ^a   Huntley, Mark E ^a   Olaizola, Miguel ^a  

^a Mera Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; FOOD PRODUCTS; MEDICAL PROBLEMS; TISSUE;

HEALTH MANAGEMENT;

NUTRITION;

ASTAXANTHIN; CAROTENOID;

ANTIOXIDANT; BIOTECHNOLOGY; PROTIST;

ALGA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; DEGENERATIVE DISEASE; DRUG BIOAVAILABILITY; DRUG SAFETY; EYE; HAEMATOCOCCUS PLUVIALIS; IMMUNE RESPONSE; ISCHEMIC HEART DISEASE; LIVER FUNCTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION PROTECTION; REVIEW; SKIN; SUPPLEMENTATION; ULTRAVIOLET RADIATION;

ALGAE; HAEMATOCOCCUS; HAEMATOCOCCUS PLUVIALIS; PLUVIALIS; PROTISTA;

EID: 0037407158     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(03)00078-7     Document Type: Review

References (65)

1. Lorenz R.T., Cysewski G.R. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol. 18:2000;160-167.
2. Olaizola M., Huntley M.E. Recent advances in commercial production of astaxanthin from microalgae. Fingerman M., Nagabhushanam R. Biomaterials and Bioprocessing. 2003;Science Publishers.
3. Turujman S.A., et al. Rapid liquid chromatographic method to distinguish wild salmon from aquacultured salmon fed synthetic astaxanthin. J. AOAC Int. 80:1997;622-632.
4. Jyonouchi H., et al. Effect of carotenoids on in vitro immunoglobulin production by human peripheral blood mononuclear cells: astaxanthin, a carotenoid without vitamin A activity, enhances in vitro immunoglobulin production in response to a T-dependent stimulant and antigen. Nutr. Cancer. 23:1995;171-183.
5. Furr H.C., Clark R.M. Intestinal absorption and tissue distribution of carotenoids. J. Nutr. Biochem. 8:1997;364-377.
6. Østerlie M., et al. Plasma appearance and distribution of astaxanthin E/Z isomers in plasma lipoproteins of after single dose administration of astaxanthin. J. Nutr. Biochem. 11:2000;482-490.
7. Papas A.M. Antioxidant Status, Diet, Nutrition, and Health. 1999;CRC Press.
8. Mortensen A., et al. Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants. FEBS Lett. 418:1997;91-97.
9. Beutner S., et al. Quantitative assessment of antioxidant properties of natural colorants and phytochemicals: carotenoids, flavonoids, phenols and indigoids. The role of β-carotene in antioxidant functions. J. Sci. Food Agric. 81:2001;559-568.
10. Palozza P., Krinsky N.I. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys. 297:1992;291-295.
11. Naguib Y.M.A. Antioxidant acitivities of astaxanthin and related carotenoids. J. Agric. Food Chem. 48:2000;1150-1154.
12. Kurashige M., et al. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol. Chem. Phys. Med. NMR. 22:1990;27-38.
13. Shimidzu N., et al. Carotenoids as singlet oxygen quenchers in marine organisms. Fish. Sci. 62:1996;134-137.
14. O'Connor I., O'Brien N. Modulation of UVA light-induced oxidative stress by beta-carotene, lutein and astaxanthin in cultured fibroblasts. J. Dermatol. Sci. 16:1998;226-230.
15. Jacques P. The potential preventive effects of vitamins for cataract and age-related macular degeneration. Int. J. Vitam. Nutr. Res. 69:1999;198-205.
16. Lyle B.J., et al. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am. J. Epidemiol. 149:1999;801-809.
17. Seddon J.M., et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. J. Am. Med. Assoc. 272:1994;1413-1420.
18. Landrum J.T., et al. Analysis of zeaxanthin distribution within individual human retinas. Methods Enzymol. 299:1999;457-467.
19. Tso, M.O.M. and Lam, T-T. (1996) Method of Retarding and Ameliorating Central Nervous System and Eye Damage. U.S. Patent #5527533.
20. Fuchs J. Potentials and limitations of the natural antioxidants RRR-alpha-tocopherol, L-ascorbic acid and beta-carotene in cutaneous photoprotection. Free Radic. Biol. Med. 25:1998;848-873.
21. Lee J., et al. Carotenoid supplementation reduces erythema in human skin after simulated solar radiation exposure. Proc. Soc. Exp. Biol. Med. 223:2000;170-174.
22. Stahl W., et al. Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans. Am. J. Clin. Nutr. 71:2000;795-798.
23. Meyers, S.P. (1993) The biological role of astaxanthin in salmonids and other aquatic species. First International Symposium on Nat. Colors for Foods, Nutraceuticals, Beverages and Confectionary, Amherst, USA.
24. Torissen O.J., et al. Pigmentation of salmonids - carotenoid deposition and metabolism. CRC Crit. Rev. Aquat. Sci. 1:1989;209-225.
25. Savoure N., et al. Vitamin A status and metabolism of cutaneous polyamines in the hairless mouse after UV irradiation: action of β-carotene and astaxanthin. Int. J. Vitam. Nutr. Res. 65:1995;79-86.
26. Black H. Radical interception by carotenoids and effects on UV carcinogenesis. Nutr. Cancer. 31:1998;212-217.
27. Aghdassi E., Allard J.P. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic. Biol. Med. 28:2000;880-886.
28. Aw T.Y. Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. Am. J. Clin. Nutr. 70:1999;557-565.
29. Greene L. Asthma and oxidant stress: nutritional, environmental, and genetic risk factors. J. Am. Coll. Nutr. 14:1995;317-324.
30. Dekkers J., et al. The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports Med. 21:1996;213-238.
31. Bennedsen M., et al. Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol. Lett. 70:1999;185-189.
32. Frei B. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation. Crit. Rev. Food Sci. Nutr. 35:1995;83-98.
33. Kritchevsky S.B. β-Carotene, carotenoids and the prevention of coronary heart disease. J. Nutr. 129:1999;5-8.
34. Miki, W. et al. (1998) Astaxanthin-Containing Drink. Japanese Patent #10155459.
35. Murillo E. Efecto hipercolesterolémico de la cantaxantina y la astaxantina en ratas. Arch. Latinoam. Nutr. 42:1992;409-413.
36. Tracy R.P. Inflammation markers and coronary heart disease. Curr. Opin. Lipidol. 10:1999;435-441.
37. Gershon D. The mitochondrial theory of aging: Is the culprit a faulty disposal system rather than indigenous mitochondrial alterations? Exp. Gerontol. 34:1999;613-619.
38. Goto S., et al. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim. Biophys. Acta. 1512:2001;251-258.
39. Barros M.P., et al. Astaxanthin and peridinin inhibit oxidative damage in Fe2+-loaded liposomes: Scavenging oxyradicals or changing membrane permeability? Biochem. Biophys. Res. Commun. 288:2001;225-232.
40. Matsushita Y., et al. Antioxidant activity of polar carotenoids including astaxanthin-β-glucoside from marine bacterium on PC liposomes. Fish. Sci. 66:2000;980-985.
41. Allen R.G., Tresini M. Oxidative stress and gene regulation. Free Radic. Biol. Med. 28:2000;463-499.
42. Bertram J.S. Carotenoids and gene regulation. Nutr. Rev. 57:1999;182-191.
43. Kistler A., et al. Metabolism and CYP-inducer properties of astaxanthin in man and primary human hepatocytes. Arch. Toxicol. 75:2002;665-675.
44. Tanaka T., et al. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis. 15:1994;15-19.
45. Tanaka T., et al. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer Res. 55:1995;4059-4064.
46. Tanaka T., et al. Suppression of azomethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis. 16:1995;2957-2963.
47. Chew B.P., et al. A comparison of the anticancer activities of dietary β-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res. 19:1999;1849-1854.
48. Anderson, M. (2001) Method of Inhibiting 5-α Reductase with Astaxanthin to Prevent and Treat Begnign Prostate Hyperplasia (BPH) and Prostate Cancer in Human Males. US Patent #6277417.
49. Kurihara H., et al. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci. 70:2002;2509-2520.
50. Jewell C., O'Brien N. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br. J. Nutr. 81:1999;235-242.
51. Jyonouchi H., et al. Antitumor activity of astaxanthin and its mode of action. Nutr. Cancer. 36:2000;59-65.
52. Gradelet S., et al. Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic foci and DNA damage in the rat: role of the modulation of aflatoxin B1 metabolism. Carcinogenesis. 19:1998;403-411.
53. Hughes D.A. Effects of dietary antioxidants on the immune function of middle-aged adults. Proc. Nutr. Soc. 58:1999;79-84.
54. Jyonouchi H., et al. Studies of immunomodulating actions of carotenoids. II. Astaxanthin enhances in vitro antibody production to T-dependent antigens without facilitating polyclonal B-cell activation. Nutr. Cancer. 19:1993;269-280.
55. Jyonouchi H., et al. Immunomodulating actions of carotenoids: enhancement of in vivo and in vitro antibody production to T-dependent antigens. Nutr. Cancer. 21:1994;47-58.
56. Okai Y., Higashi-Okai K. Possible immunomodulating activities of carotenoids in in vitro cell culture experiments. Int. J. Immunopharmacol. 18:1996;753-758.
57. Jyonouchi H., et al. Astaxanthin, a carotenoid without vitamin A activity, augments antibody responses in cultures including T-helper cell clones and suboptimal doses of antigen. J. Nutr. 124:1995;2483-2492.
58. Facchinetti F., et al. Free radicals as mediators of neuronal injury. Cell. Mol. Neurobiol. 18:1998;667-682.
59. Grant W.B. Dietary links to Alzheimer's disease. J. Alzheimers Dis. 2:1997;42-55.
60. Borlongan C., et al. Free radical damage and oxidative stress in Huntington's disease. J. Fla. Med. Assoc. 83:1996;335-341.
61. de Rijk M., et al. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch. Neurol. 54:1997;762-765.
62. Ferrante R., et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69:1997;2064-2074.
63. Mera Pharmaceuticals (1999) Haematococcus pluvialis and astaxanthin safety for human consumption. Technical Report TR.3005.001 available at http://www.astafactor.com/techreports/tr3005-001.htm .
64. Bahner B. Vitamin E health studies boosting demand and sales. Chem. Mark. Rep. 244:1993;26-27.
65. Bahner B. Beta-carotene use grows; natural sector in flux. Chem. Mark. Rep. 244:1993;16-17.